155 related articles for article (PubMed ID: 1416848)
1. Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination.
Summanen P; Wexler HM; Finegold SM
Antimicrob Agents Chemother; 1992 Aug; 36(8):1658-64. PubMed ID: 1416848
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of medium composition and atmospheric conditions on detection of Bilophila wadsworthia beta-lactamase by cefinase and cefinase plus methods.
Summanen PH
J Clin Microbiol; 2000 Feb; 38(2):733-6. PubMed ID: 10655376
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal activity of selected antimicrobial agents against Bilophila wadsworthia and Bacteroides gracilis.
Baron EJ; Ropers G; Summanen P; Courcol RJ
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S339-43. PubMed ID: 8324144
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
[TBL] [Abstract][Full Text] [Related]
5. Morphological response of Bilophila wadsworthia to imipenem: correlation with properties of penicillin-binding proteins.
Summanen P; Wexler HM; Lee K; Becker SA; Garcia MM; Finegold SM
Antimicrob Agents Chemother; 1993 Dec; 37(12):2638-44. PubMed ID: 8109929
[TBL] [Abstract][Full Text] [Related]
6. Bilophila wadsworthia: a unique Gram-negative anaerobic rod.
Baron EJ
Anaerobe; 1997; 3(2-3):83-6. PubMed ID: 16887567
[TBL] [Abstract][Full Text] [Related]
7. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents --special references to bacteria isolated between April 2008 and March 2009].
Shinagawa N; Hasegawa M; Hirata K; Furuhata T; Mizukuchi T; Osanai H; Yanai Y; Hata F; Sasaki K; Someya T; Harada K; Oono K; Tokita S; Nakamura M; Shibuya H; Hasegawa I; Kimura M; Oshima H; Maeda H; Mukaiya M; Kihara C; Kosho W; Hoshikawa T; Kimura H; Ushijima Y; Yae-Hoon Y; Aikawa N; Abe S; Yura J; Takeyama H; Wakasugi T; Taniguchi M; Mizuno I; Fukui T; Mashita K; Ishikawa S; Mizuno A; Moori N; Sumita N; Kubo S; Lee S; Oomura T; Kobayashi Y; Tsuji T; Yamaue H; Kawai M; Takesue Y; Tanaka N; Kimura H; Iwagaki H; Sueda T; Hiyama E; Murakami Y; Ooge H; Uemura K; Tsumura H; Yokoyama T; Takeuchi H; Tanakaya K; Yasunami Y; Ryu S
Jpn J Antibiot; 2010 Apr; 63(2):105-70. PubMed ID: 20919496
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
Dornbusch K; Nord CE; Olsson-Liljeqvist B
Scand J Infect Dis Suppl; 1979; (19):17-25. PubMed ID: 37593
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of the anaerobic gram-negative non-sporulating rod, Bilophila wadsworthia to beta-lactams, beta-lactamase inhibitors, meropenem, metronidazole, clindamycin and quinolones.
Schumacher UK; Single B
Zentralbl Bakteriol; 1998 May; 287(4):421-5. PubMed ID: 9638871
[TBL] [Abstract][Full Text] [Related]
10. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2003 and March 2004].
Shinagawa N; Taniguchi M; Hirata K; Katsuramaki T; Mizukuchi T; Mashita K; Ushijima Y; Ushida T; Ishikawa S; Aikawa N; Yo K; Mizuno A; Takayama T; Sato T; Kato K; Kubo S; Suehiro S; Yura J; Fujimoto M; Manabe T; Takeyama H; Tanimura H; Taniguchi K; Hasegawa M; Yamaue H; Ohnishi H; Tanaka N; Iwagaki H; Kimura H; Tsumura H; Fuchimoto S; Yokoyama T; Sueda T; Takesue Y; Takeuchi H; Yasui Y; Hiyama E; Ikeda S; Yasunami Y
Jpn J Antibiot; 2006 Apr; 59(2):72-116. PubMed ID: 16805318
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of faropenem against 579 strains of anaerobic bacteria.
Wexler HM; Molitoris D; St John S; Vu A; Read EK; Finegold SM
Antimicrob Agents Chemother; 2002 Nov; 46(11):3669-75. PubMed ID: 12384389
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Jones RN; Pfaller MA; Doern GV; Erwin ME; Hollis RJ
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):215-28. PubMed ID: 9572029
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of Bilophila wadsworthia.
Finegold S; Summanen P; Hunt Gerardo S; Baron E
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1058-63. PubMed ID: 1295759
[TBL] [Abstract][Full Text] [Related]
14. Comparative
Goldstein EJC; Citron DM; Tyrrell KL; Leoncio E; Merriam CV
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158284
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections.
Blandino G; Milazzo I; Fazio D; Puglisi S; Pisano M; Speciale A; Pappalardo S
J Chemother; 2007 Oct; 19(5):495-9. PubMed ID: 18073147
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the E-test and reference agar dilution method for susceptibility of gram-negative anaerobic organisms.
Couroux PR; Massey VE; Schieven BC; Lannigan R; Hussain Z
Am J Clin Pathol; 1993 Sep; 100(3):301-3. PubMed ID: 8379540
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility testing of Bilophila wadsworthia isolates submitted for routine laboratory examination.
Mochida C; Hirakata Y; Matsuda J; Iori F; Ozaki Y; Nakano M; Hamaguchi K; Izumikawa K; Yamaguchi T; Tomono K; Maesaki S; Yamada Y; Kohno S; Kamihira S
J Clin Microbiol; 1998 Jun; 36(6):1790-2. PubMed ID: 9620424
[TBL] [Abstract][Full Text] [Related]
19. [Bilophila wadsworthia isolated from surgical specimens].
Shinagawa N; Yura J; Takeyama H; Taniguchi M
Jpn J Antibiot; 2006 Dec; 59(6):452-8. PubMed ID: 17334062
[TBL] [Abstract][Full Text] [Related]
20. [Bacteria isolated from surgical infections and their susceptibility to antimicrobial agents--special reference to bacteria isolated between April 2007 and March 2008].
Shinagawa N; Hasegawa M; Hirata K; Katsuramaki T; Mizukuchi T; Ushijima Y; Ushida T; Aikawa N; Yo K; Yura J; Takeyama H; Wakasugi T; Taniguchi M; Mizuno I; Mashita K; Ishikawa S; Mizuno A; Tsumura H; Yokoyama T; Moori N; Sumita N; Kubo S; Lee S; Oomura T; Kobayashi Y; Tsuji T; Yamaue H; Kawai M; Takesue Y; Tanaka N; Kimura H; Iwagaki H; Sueda T; Hiyama E; Murakami Y; Ooge H; Uemura K; Takeuchi H; Yasui Y; Yasunami Y; Ryu S
Jpn J Antibiot; 2009 Aug; 62(4):277-340. PubMed ID: 19860320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
